Noramco, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Noramco, Inc. - overview
Established
1979
Location
Wilmington, DE, US
Primary Industry
Pharmaceuticals
About
Founded in 1979 and based in Delaware, US, Noramco, Inc. operates as a manufacturer of cannabinoids, naloxone hydrochlorides, and other active ingredients used in pharmaceutical products that treat attention deficit hyperactivity disorder, pain, and addiction.
Current Investors
SK Capital
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.noramco.com
Verticals
E-commerce, Manufacturing
Company Stage
Mature - Buyout
Total Amount Raised
Subscriber access only
Noramco, Inc. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Trade Sale | Announced | Noramco, Inc. | - | ||||||||
| Add-on, Spin-Off, Trade Sale | Completed | Cambrex Corporation's Drug Product Business Unit | - | ||||||||
| Spin-Off | Completed | Purisys | - | ||||||||
| Buyout | Completed | Noramco, Inc. | - |
Displaying 1 - 4 of 4
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.